NNC-19-1228
N/A
Report date: 2023/04/23 16:11:39
NME
Base Information
Drug NameNNC-19-1228
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A